M

Marrone Bio Innovations Inc
F:0MB

Watchlist Manager
Marrone Bio Innovations Inc
F:0MB
Watchlist
Price: 0.965 EUR -3.02% Market Closed
Market Cap: €176m

EV/EBITDA

-14.8
Current
8%
More Expensive
vs 3-y average of -13.7

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
-14.8
=
Enterprise Value
€174.4m
/
EBITDA
$-13.9m

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
-14.8
=
Enterprise Value
€174.4m
/
EBITDA
$-13.9m

Valuation Scenarios

Marrone Bio Innovations Inc is trading above its industry average

If EV/EBITDA returns to its Industry Average (11), the stock would be worth €-0.72 (174% downside from current price).

Statistics
Positive Scenarios
0/2
Maximum Downside
-197%
Maximum Upside
No Upside Scenarios
Average Downside
185%
Scenario EV/EBITDA Value Implied Price Upside/Downside
Current Multiple -14.8 €0.97
0%
Industry Average 11 €-0.72
-174%
Country Average 14.4 €-0.93
-197%

Forward EV/EBITDA
Today’s price vs future ebitda

Not enough data available to calculate forward EV/EBITDA

Peer Comparison

All Multiples
EV/EBITDA
P/E
All Countries
Close

Market Distribution

Lower than 100% of companies in the United States of America
Percentile
0th
Based on 9 875 companies
0th percentile
-14.8
Low
0 — 10
Typical Range
10 — 21.5
High
21.5 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 10
Median 14.4
70th Percentile 21.5
Max 1 767 274.1

Marrone Bio Innovations Inc
Glance View

Market Cap
176m EUR
Industry
Chemicals

Marrone Bio Innovations, Inc. engages in the provision of biological-based solutions for agricultural crops, turf protection, seed treatment, plant health and waterway systems. The company is headquartered in Raleigh, North Carolina and currently employs 153 full-time employees. The company went IPO on 2013-08-02. The Company’s products include Emergen, Foramin, Foramin ST, Grandevo, Haven, Jet-Ag, Jet-Oxide, Majestene, Pacesetter, Regalia, Stargus, UBP, UBP ST, Venerate and Zelto. Its product categories include products, which are referred to as biopesticides, bioinsecticides, bionematicides, biofungicides, biostimulants and bionutrition. Its pipeline consists of products in three categories: bioprotection, seed and soil health, and plant health. The Company’s markets include row crops, such as corn and soybeans; fruits and vegetables, such as tomatoes, leafy greens and cucurbits, trees; nuts and vines, such as almonds and grapes, and greenhouse production, such as ornamentals and medicinal plants.

0MB Intrinsic Value
Not Available
M
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett